13 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
in the event of a security incident. These types of mandatory disclosures are costly, could lead to negative publicity, and may cause our partners to lose
ARS
lk6a dxyaz6dq4mms4k
28 Apr 23
Annual report to shareholders
7:03am
S-3ASR
EX-1.2
3qew8rox
10 Nov 21
Automatic shelf registration
5:19pm
S-1
EX-10.14
sj4gppkp 2mfmp8dp
10 Sep 20
IPO registration
5:26pm
S-1
EX-3.4
fon2rrjp 5i
10 Sep 20
IPO registration
5:26pm
DRS
EX-3.3
cnbyddt
6 Aug 20
Draft registration statement
12:00am
DRS
EX-10.9
wcvmk5hcvrwpqbofqrb7
6 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next